Sequent Scientific (VIYASH) Share Price falls 7.49% today; Mid Cap stock turns lower
- October 21, 2026
- Posted by: Kunal Singla
- Category: News
Sequent Scientific Share Price is trading at Rs 204.50 after a 7.49% decline, with market capitalisation at Rs 9,765.18 Cr. The move places Sequent Scientific Share Price in focus for investors following healthcare stocks, even though the day’s move can be described only by the verified price data. The stock opened at Rs 222.65, touched a high of Rs 222.65 and a low of Rs 204.30, and remained below the opening level as of 21 October 2026 at 2:52:51 PM IST. The price move is confirmed in Univest data; a company-specific reason has not been established. For readers tracking Sequent Scientific Share Price Today, the key question is not only what changed in price, but also how the current valuation and sector positioning compare with listed peers.
Sequent Scientific Share Price also matters because the company sits in the Mid Cap category and trades in the Pharmaceuticals & Drugs space within Healthcare. That combination makes the stock useful for both event-based tracking and fundamental analysis. The latest Univest figures show a clear same-day share price decline, while the broader valuation profile gives context for why the stock is attracting attention in Sequent Scientific Stock News and Sequent Scientific Share Price News discussions.
Sequent Scientific (VIYASH) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 204.5 |
| Previous Close | Rs 221.05 |
| Today's Move | -Rs 16.55 (-7.49%) |
| Open | Rs 222.65 |
| High | Rs 222.65 |
| Low | Rs 204.3 |
| Market Capitalisation | Rs 9,765.18 crore |
| Market Cap Category | Mid Cap |
Sequent Scientific Share Price moved from the previous close of Rs 221.05 to Rs 204.50, a fall of Rs 16.55 or 7.49%. The stock opened at Rs 222.65, which was also the day high, and then traded down to a low of Rs 204.30 before last trading at Rs 204.50. That range shows a clear intraday reset in Sequent Scientific Share Price Today terms, with the stock remaining well below the opening level through the reported time. Market capitalisation stood at Rs 9,765.18 Cr, and the company is classified as a Mid Cap stock. For investors tracking Sequent Scientific Share Price Live, the immediate takeaway is the magnitude of the share price fall rather than any unstated cause. Univest data confirms the move, and the next step is to see whether fundamentals and sector benchmarks place the valuation in a different light.
The day’s range also frames Sequent Scientific Share Price Update coverage: the stock traded between Rs 222.65 and Rs 204.30, with the current price near the lower end of that band. That makes Sequent Scientific Stock Performance an event-led topic for market participants who follow healthcare names. The price action now leads naturally into Sequent Scientific Fundamental Analysis.
Sequent Scientific (VIYASH) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 9,765.18 crore |
| P/E Ratio | 57.05x |
| P/B Ratio | 3.47x |
| ROE | 9.06% |
| ROCE | 13.1% |
| EPS | Rs 3.87 |
| Book Value Per Share | Rs 63.66 |
| Dividend Yield | 0% |
Sequent Scientific (VIYASH) fundamental metrics show P/E 57.05x, P/B 3.47x, ROE 9.06%, ROCE 13.1%. These ratios show where the company stands today and are not a call to buy or sell.
Sequent Scientific has a market capitalisation of Rs 9,765.18 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 57.05x, P/B at 3.47x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.06% and ROCE of 13.1%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 3.87, book value per share of Rs 63.66, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 57.05x |
| Benchmark Median P/E | 31.73x |
| Benchmark Average P/E | 45.98x |
| Benchmark P/E Range | 3.1x to 616.89x |
| Company P/B Ratio | 3.47x |
| Benchmark Median P/B | 2.76x |
| Benchmark Average P/B | 4.11x |
| Company ROE | 9.06% |
| Benchmark Median ROE | 11.33% |
| Benchmark Average ROE | 10.14% |
| Company ROCE | 13.1% |
| Benchmark Median ROCE | 13.25% |
| Benchmark Average ROCE | 13.05% |
| Company Market Capitalisation | Rs 9,765.18 crore |
| Benchmark Median Market Cap | Rs 771.43 crore |
| Benchmark Average Market Cap | Rs 13,467.03 crore |
Sequent Scientific (VIYASH) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Sequent Scientific (VIYASH) has a P/E ratio of 57.05x, which is above the benchmark median of 31.73x, a difference of +79.8%. A P/E difference of this kind is a reference point rather than a recommendation.
Sequent Scientific (VIYASH) has a ROE of 9.06%, which is below the benchmark median of 11.33%, a difference of -20.04%. Sequent Scientific (VIYASH) has a ROCE of 13.1%, which is below the benchmark median of 13.25%, a difference of -1.13%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,18,683.95 | 34.61 | 4.84 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,41,310.94 | 82.5 | 13.66 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,73,078.79 | 79.36 | 19.28 | 26.76 | 19.27 |
| Laurus Labs | LAURUSLABS | 1,11,433.99 | 101.92 | 19.76 | 18.31 | 18.2 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,022.18 | 24.6 | 4.12 | 19.69 | 21.39 |
Sequent Scientific (VIYASH) has a P/E ratio of 57.05x compared with the displayed peer median of 79.36x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 9.06% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 13.1% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Sequent Scientific (VIYASH) has a market capitalisation of Rs 9,765.18 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Sequent Scientific
- Sequent Scientific Share Price fell 7.49% to Rs 204.50, making the latest move a clear event for price tracking.
- The stock traded below its opening level of Rs 222.65 and touched an intraday low of Rs 204.30.
- Sequent Scientific Market Cap stands at Rs 9,765.18 Cr, placing it in the Mid Cap category.
- The P/E ratio of 57.05 is above the same-industry median and average, which keeps valuation in focus.
- ROE of 9.06% and ROCE of 13.1% give investors a quick read on earnings efficiency versus peers.
About Sequent Scientific
Sequent Scientific operates in Healthcare and the Pharmaceuticals & Drugs industry. The company is followed as a listed Mid Cap name, and its business is assessed through the standard lenses of earnings, book value, return ratios and peer valuation. Sequent Scientific Share Price is therefore watched not only for daily movement but also for how the company is positioned within the broader pharmaceutical pack. The company description provided in the market snapshot is to sector and industry classification, so the factual view stays anchored to those verified identifiers and the published financial ratios. For Sequent Scientific Stock Performance, investors typically compare the company with other listed pharmaceuticals names on valuation and returns.
Track Sequent Scientific Share Price on Univest
Use Sequent Scientific (VIYASH) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Investors can track Sequent Scientific Share Price on Univest for live updates, valuation ratios, 52-week levels and market insights in one place. Univest also helps readers review Sequent Scientific Share Price Today, fundamental ratios and healthcare sector context without switching between multiple sources. For those following Sequent Scientific Latest News, the platform is useful for monitoring price action and key financial metrics together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Sequent Scientific Share Price fall today?
Ans. Sequent Scientific Share Price fell 7.49% to Rs 204.50 from the previous close of Rs 221.05. The price move is confirmed in Univest data; a company-specific reason has not been established.
What is Sequent Scientific Share Price today?
Ans. Sequent Scientific Share Price is Rs 204.50 as of 21 October 2026 at 2:52:51 PM IST. The stock was lower by Rs 16.55 from the previous close and traded within an intraday range of Rs 204.30 to Rs 222.65.
How much did Sequent Scientific Share Price decline?
Ans. Sequent Scientific Share Price declined by Rs 16.55, which equals 7.49% for the latest session. The move started from a previous close of Rs 221.05 and left the stock at Rs 204.50.
What is the market capitalisation of Sequent Scientific ?
Ans. Sequent Scientific Market Cap stands at Rs 9,765.18 Cr. The company is classified as a Mid Cap stock, which places it above the benchmark median market capitalisation in the same industry set.
What does Sequent Scientific Fundamental Analysis show?
Ans. Sequent Scientific Fundamental Analysis shows a P/E of 57.05, P/B of 3.47, ROE of 9.06%, ROCE of 13.1%, EPS of Rs 3.87 and book value of Rs 63.66. Dividend yield is 0.
How does Sequent Scientific compare with healthcare peers?
Ans. Compared with listed peers such as Sun Pharma, Cipla and Zydus Lifesciences, Sequent Scientific trades on a higher P/E than several names, while its ROE is lower than the stronger-return peers in the same industry group.
Is Sequent Scientific Share Price expensive versus the sector?
Ans. Sequent Scientific Share Price sits above the same-industry median P/E of 31.73 and the median P/B of 2.76. That suggests a richer earnings valuation than the benchmark middle, even though ROCE is near the industry average.
What is the 2026 intraday range for Sequent Scientific Share Price?
Ans. Sequent Scientific Share Price moved between Rs 204.30 and Rs 222.65 in the reported trade. The day high matched the opening price, while the low came close to the current price at the time of reporting.
Where can investors track Sequent Scientific Share Price and stock news?
Ans. Investors can track Sequent Scientific Share Price on Univest along with valuation ratios, market cap and healthcare peer context. That keeps Sequent Scientific Stock News, price action and fundamentals in one place for quick review.
